CAIRE Inc. Company Profile

Background

Overview

CAIRE Inc., headquartered in Ball Ground, Georgia, is a leading global manufacturer specializing in oxygen supply equipment. With over 50 years of experience, the company offers innovative products and services for home care, hospice, long-term care, hospitals, military, and industrial applications. CAIRE's mission is to support and inspire customers to live healthier and more productive lives by continuously developing breakthrough oxygen products and services.

Vision

CAIRE aims to lead the oxygen supply industry into the future by offering unmatched focus and expertise, expanding the uses of oxygen delivery in medical and commercial applications.

Key Strategic Focus

Core Objectives

Develop and provide advanced oxygen delivery solutions.

Expand applications of oxygen therapy across various sectors.

Maintain leadership in the oxygen supply industry through innovation.

Areas of Specialization

Portable and stationary oxygen therapy devices.

On-site oxygen generation solutions for medical and industrial use.

Telehealth integration for respiratory care.

Key Technologies Utilized

Proprietary breath detection technology.

Automated oxygen dose adjustment systems.

Telehealth platforms for remote patient monitoring.

Primary Markets Targeted

Home healthcare.

Hospitals and long-term care facilities.

Military and aerospace sectors.

Industrial applications requiring oxygen supply.

Financials and Funding

Revenue

As of June 2025, CAIRE Inc.'s annual revenue reached $750 million.

Funding History

In October 2018, CAIRE was acquired by Niterra Co., Ltd. (formerly NGK SPARK PLUG CO., LTD.), enhancing its innovation and growth capabilities.

Pipeline Development

Key Products

FreeStyle® Comfort® Portable Oxygen Concentrator: A lightweight device with advanced breath detection technology, offering up to seven hours of battery life.

Eclipse 5 Portable Oxygen Concentrator: Features both continuous and pulse flow settings, suitable for various oxygen therapy needs.

Companion 5 Stationary Oxygen Concentrator: Designed for home use, providing continuous flow oxygen therapy.

Recent Developments

In 2024, CAIRE launched the "IntenOxy 5" stationary oxygen concentrator, aiming to provide effective oxygen delivery with minimal maintenance and reduced operating expenses.

Technological Platform and Innovation

Proprietary Technologies

Automat Technology: Advanced breath detection system ensuring optimal oxygen delivery.

Telehealth Integration: Platforms like myCAIRE for remote patient monitoring and management.

Significant Scientific Methods

Use of Fractional Exhaled Nitric Oxide (FeNO) measurement for assessing allergic inflammation in asthmatic patients.

Leadership Team

Ken Hosako: President and Chief Executive Officer.

Paul Abbott: Chief Financial Officer.

Norbert Leinfellner, PhD: Executive Vice President of Global Engineering.

Ruud Vullers: Executive Vice President of Global Operations.

Mario Bolivar: Vice President of Global Sales, Onsite Generation at AirSep.

Josep Fernandez: Vice President of Global Sales and Marketing.

William Hampton: Vice President and Global Controller.

Carole Harris: Vice President of Global Regulatory Affairs & Quality Assurance.

Larry Hughes: Vice President and General Manager of AirSep Commercial Products.

Frank Hutchison: Vice President of Global IT.

Yoon Shin: Chief Administrative Officer, Chief Compliance Officer, and General Counsel.

Leadership Changes

Paul Abbott: Joined as Chief Financial Officer in April 2023.

Norbert Leinfellner, PhD: Appointed Executive Vice President of Global Engineering in September 2024.

Carole Harris: Joined as Vice President of Global Regulatory Affairs & Quality Assurance in November 2024.

Frank Hutchison: Appointed Vice President of Global IT in September 2024.

Competitor Profile

Market Insights and Dynamics

The global oxygen therapy equipment market is experiencing significant growth due to the increasing prevalence of respiratory diseases and advancements in technology.

Competitor Analysis

Inogen, Inc.: Specializes in portable oxygen concentrators with a focus on direct-to-consumer sales.

Philips Respironics: Offers a range of respiratory care solutions, including oxygen concentrators and ventilators.

Invacare Corporation: Provides medical equipment, including stationary and portable oxygen concentrators.

Strategic Collaborations and Partnerships

Spirosure Acquisition: In June 2020, CAIRE acquired Spirosure, Inc., enhancing its capabilities in measuring FeNO, a key indicator of allergic inflammation in asthmatic patients.